Aclarion publishes CEO letter on reimbursement progress and trial timeline
Go back to Aclarion publishes CEO letter on reimbursement progress and trial timeline| (NASDAQ: ACON) | Delayed: 2.37 +0.08 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.29 | 52 Week High | $ | |||
| Open | $2.28 | 52 Week Low | $ | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $ | |||
| Volume | 31,620 | |||||
| (NASDAQ: ACONW) | Delayed: 0.03 +0.01 (50.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 4,734 | |||||
